ATE440888T1 - Verfahren zur herstellung von glatiramer - Google Patents

Verfahren zur herstellung von glatiramer

Info

Publication number: ATE440888T1
Authority: AT; Austria
Prior art keywords: glatiramer; producing; producing glatiramer
Prior art date: 2004-10-29

Application number

AT05824006T

Other languages

English (en)

Inventor

Anup Ray

Hiren Patel

Johannes Ludescher

Mariappan Anbazhagan

Mahendra Patel

Ingolf Macher

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-29

Filing date

2005-10-27

Publication date

2009-09-15

2005-10-27 Application filed by Sandoz Ag filed Critical Sandoz Ag

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE440888T1 publication Critical patent/ATE440888T1/de

Links

YLOCGHYTXIINAI-XKUOMLDTSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 YLOCGHYTXIINAI-XKUOMLDTSA-N 0.000 title 1
108010072051 Glatiramer Acetate Proteins 0.000 title 1
229940042385 glatiramer Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polyamides (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT05824006T 2004-10-29 2005-10-27 Verfahren zur herstellung von glatiramer ATE440888T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US62334604P	2004-10-29	2004-10-29
US65153505P	2005-02-09	2005-02-09
US65137205P	2005-02-09	2005-02-09
US72390105P	2005-10-05	2005-10-05
PCT/US2005/039003 WO2006050122A1 (en)	2004-10-29	2005-10-27	Processes for preparing glatiramer

Publications (1)

Publication Number	Publication Date
ATE440888T1 true ATE440888T1 (de)	2009-09-15

Family

ID=36046637

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05824006T ATE440888T1 (de)	2004-10-29	2005-10-27	Verfahren zur herstellung von glatiramer

Country Status (14)

Country	Link
US (5)	US20060154862A1 (de)
EP (1)	EP1807467B1 (de)
JP (1)	JP5297653B2 (de)
CN (1)	CN101044188B (de)
AR (1)	AR052321A1 (de)
AT (1)	ATE440888T1 (de)
AU (1)	AU2005302500B2 (de)
CA (1)	CA2583589C (de)
DE (1)	DE602005016292D1 (de)
ES (1)	ES2331015T3 (de)
IL (2)	IL182581A (de)
SI (1)	SI1807467T1 (de)
TW (1)	TWI307349B (de)
WO (1)	WO2006050122A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1459065B1 (de)	2001-12-04	2010-07-28	Teva Pharmaceutical Industries, Ltd.	Verfahren zur messung der wirkstärke von glatirameracetat
HRP20160455T1 (hr)	2004-09-09	2016-07-15	Yeda Research And Development Co., Ltd.	Smjese polipeptida, sastavi koji ih sadrže i postupci za njihovu pripremu, te njihove primjene
DE602005016292D1 (de) *	2004-10-29	2009-10-08	Sandoz Ag	Verfahren zur herstellung von glatiramer
US20070161566A1 (en) *	2006-01-11	2007-07-12	Teva Pharmaceutical Industries, Ltd.	Method of treating multiple sclerosis
SI2046817T1 (sl) *	2006-07-05	2010-04-30	Momenta Pharmaceuticals Inc	IzboljĹˇani postopek za pripravo kopolimera-1
ES2477232T5 (es)	2007-06-21	2017-11-23	Momenta Pharmaceuticals, Inc.	Análisis de copolímeros
US20090035816A1 (en) *	2007-08-02	2009-02-05	Scinopharm Taiwan Ltd.	Process for the preparation of a polypeptide
ES2449865T5 (es)	2008-04-16	2022-11-18	Momenta Pharmaceuticals Inc	Análisis de composiciones de copolímeros de aminoácidos
PL2307448T3 (pl)	2008-08-07	2015-10-30	Sigma Aldrich Co Llc	Wytwarzanie polilizyny i poliornityny o małym ciężarze cząsteczkowym z wysoką wydajnością
KR20110059606A (ko) *	2008-08-07	2011-06-02	시노팜 타이완 리미티드	글라티라머 아세테이트의 합성
AR074881A1 (es)	2008-12-24	2011-02-16	Synthon Bv	Un proceso para purificar una mezcla de polimeros
RU2011144566A (ru)	2009-04-03	2013-05-10	Момента Фармасьютикалз, Инк.	Контроль сополимерных композиций
PT2275086E (pt)	2009-07-15	2012-05-18	Teva Pharma	Formulação de volume reduzido de acetato de glatirâmero e métodos de administração
US8920373B2 (en)	2009-07-15	2014-12-30	Teva Pharmaceutical Industries, Ltd.	Reduced volume formulation of glatiramer acetate and methods of administration
RS55607B1 (sr)	2009-08-20	2017-06-30	Yeda Research & Development Company Ltd	Niskofrekventna terapija glatiramer acetatom
MX2012005749A (es) *	2009-11-17	2012-10-03	Ares Trading Sa	Metodos para mejorar el diseño, la biodisponibilidad de composiciones de polimero de secuencia dirigida, por medio de la deteccion basada en proteinas del suero, de composiciones de polimero de secuencia dirigida.
USRE49251E1 (en)	2010-01-04	2022-10-18	Mapi Pharma Ltd.	Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
US8759302B2 (en)	2010-03-16	2014-06-24	Teva Pharmaceutical Industries, Ltd.	Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
MX2012012489A (es) *	2010-04-27	2012-12-17	Reddys Lab Ltd Dr	Preparacion de polipeptidos y sales de los mismos.
JP2013535474A (ja) *	2010-07-29	2013-09-12	ドクターレディズラボラトリーズリミテッド	グラチラマー酢酸塩の分子量マーカー
EA025780B1 (ru)	2010-10-11	2017-01-30	Тева Фармасьютикал Индастриз Лтд.	Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
ES2654291T3 (es)	2011-02-14	2018-02-13	Usv Private Limited	Copolímero-1, proceso para la preparación y sus métodos de análisis
WO2012114167A1 (en) *	2011-02-24	2012-08-30	Biocon Limited	Processes for the preparation of glatiramer acetate
WO2013009864A1 (en)	2011-07-11	2013-01-17	Momenta Pharmaceuticals, Inc.	Structure assessment of heterogeneous polypeptide mixtures
WO2013009885A2 (en)	2011-07-11	2013-01-17	Momenta Pharmaceuticals, Inc.	Evaluation of copolymer diethylamide
US8575198B1 (en)	2011-09-07	2013-11-05	Momenta Pharmaceuticals, Inc.	In-process control for the manufacture of glatiramer acetate
MX2014004309A (es)	2011-10-10	2015-07-06	Teva Pharma	Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
AU2012330728A1 (en) *	2011-11-03	2014-06-26	Biocon Limited	Process for the preparation of random polypeptides and employing circular dichroism as a guidance tool for the manufacture of glatiramer acetate
US20140045740A1 (en) *	2012-08-13	2014-02-13	Momenta Pharmaceuticals, Inc.	Analysis of glatiramer acetate
US9155775B1 (en)	2015-01-28	2015-10-13	Teva Pharmaceutical Industries, Ltd.	Process for manufacturing glatiramer acetate product
WO2017165664A1 (en)	2016-03-23	2017-09-28	A.L.M Holding Company	Batch asphalt mix plant
US12097292B2 (en)	2016-08-28	2024-09-24	Mapi Pharma Ltd.	Process for preparing microparticles containing glatiramer acetate
AU2017319728B2 (en)	2016-08-31	2024-09-05	Mapi Pharma Ltd	Depot systems comprising glatiramer acetate
IL316573A (en)	2017-03-26	2024-12-01	Mapi Pharma Ltd	Storage systems containing glatiramer acetate for the treatment of multiple sclerosis
CN107082796B (zh) *	2017-05-02	2020-06-09	江苏大学	一种提纯蛋白酶解物中小分子多肽的方法
GB2579600B (en)	2018-12-05	2023-07-05	Byotrol Plc	Anti-viral composition
AU2020298486B2 (en)	2019-07-01	2025-03-27	A.L.M Holding Company	Microwave heating system with suppression tunnel and related features
US12690098B2 (en)	2021-05-19	2026-07-21	A.L.M. Holding Company	Microwave waste heating system and related features
AU2022463711A1 (en)	2021-09-08	2024-03-07	A.L.M. Holding Company	Microwave heating applied to mining and related features

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2657972A (en)	1952-09-06	1953-11-03	Robert B Woodward	Copolymer of l-leucine and dl-phenylalanine
US3704282A (en)	1971-04-09	1972-11-28	Sidney Spector	Catecholamine antigens and antibodies specific therefor
IL36670A (en) *	1971-04-21	1974-09-10	Sela M	Therapeutic basic copolymers of amino acids
HU174500B (hu) *	1976-05-05	1980-01-28	Richter Gedeon Vegyeszet	Sposob poluchenija slozhnogo oktapeptidamid-sul'fatnogo ehfira kholecistokhinin-pankreozimina
JPS6053535A (ja)	1983-09-02	1985-03-27	Nitto Boseki Co Ltd	規則性ポリアミノ酸樹脂の製造方法
SU1182051A1 (ru)	1984-04-28	1985-09-30	Таджикский государственный университет им.В.И.Ленина	Политрипептиды,обладающие энантовой селективностью в реакци х гидролиза @ -нитрофениловых эфиров карбобензокси - @ - и @ -аланина
AU596986B2 (en)	1985-06-18	1990-05-24	Emory University	Biologically-active copolymers
DD257174A3 (de)	1985-12-20	1988-06-08	Ve Forschungszentrum Biotechno	Verfahren zur herstellung der peptide z-ala-ala-lon-p-nitranilid oder z-asp-phe-ome mit metalloprotease
CA2009996A1 (en)	1989-02-17	1990-08-17	Kathleen S. Cook	Process for making genes encoding random polymers of amino acids
DE3930733A1 (de)	1989-09-14	1991-03-28	Roehm Gmbh	Verfahren zur herstellung eines komplexierten arzneimittels
IL113812A (en) *	1994-05-24	2000-06-29	Yeda Res & Dev	Copolymer-1 pharmaceutical compositions containing it and its use
GB9411292D0 (en)	1994-06-06	1994-07-27	Teva Pharma	Pharmaceuticals compositions
CA2213317C (en) *	1996-01-16	2001-07-03	Lumigen, Inc.	Chemiluminescent compositions for reaction with phosphatase enzymes, and methods of use
US6271198B1 (en) *	1996-11-06	2001-08-07	Genentech, Inc.	Constrained helical peptides and methods of making same
US6214791B1 (en)	1997-01-10	2001-04-10	Yeda Research And Development Co. Ltd.	Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
US6514935B1 (en) *	1997-03-14	2003-02-04	President And Fellows Of Harvard	Methods of treating hypertension
US6632541B2 (en) *	1998-02-10	2003-10-14	Sumitomo Chemical Company, Limited	Olefin-based copolymer composition
US7906153B2 (en)	1998-04-08	2011-03-15	Theta Biomedical Consulting & Development Co., Inc.	Anti-inflammatory compositions for treating multiple sclerosis
IL141423A (en)	1998-08-27	2005-09-25	Teva Pharma	Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
US6800287B2 (en)	1998-09-25	2004-10-05	Yeda Research And Development Co., Ltd.	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US6514938B1 (en)	1998-09-25	2003-02-04	Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
AU775073C (en)	1998-11-12	2007-05-03	Yeda Research And Development Co. Ltd.	Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD
JP2000256395A (ja) *	1999-01-07	2000-09-19	Takeda Chem Ind Ltd	ポリオール類、その製造法および用途
US6872739B1 (en)	1999-06-04	2005-03-29	Vereniging Voor Christelijk Wetenshappelikjk Onderwijs	Use of riluzole for the treatment of multiple sclerosis
US6531130B1 (en)	1999-07-06	2003-03-11	The Board Of Trustees Of The Leland Stanford University	Treatment of demyelinating autoimmune disease with ordered peptides
US6963008B2 (en)	1999-07-19	2005-11-08	Teva Pharmaceutical Industries Ltd.	Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
US6995237B1 (en)	1999-10-27	2006-02-07	Cel-Sci Corporation	Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
HK1054507B (zh)	2000-01-20	2008-10-31	耶达研究及发展有限公司	共聚物1和相关肽和多肽及其处理过的t细胞在神经保护性治疗中的用途
US20020077278A1 (en) *	2000-06-05	2002-06-20	Yong V. Wee	Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002059143A2 (en)	2001-01-24	2002-08-01	President And Fellows Of Harvard College	Therapeutic peptides for demyelinating conditions
US6936599B2 (en)	2001-04-25	2005-08-30	The Regents Of The University Of California	Estriol therapy for multiple sclerosis and other autoimmune diseases
PE20030701A1 (es)	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
WO2004043995A2 (en) *	2002-11-13	2004-05-27	Apotex Pharmachem Inc.	Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine
CA2411786C (en) *	2002-11-13	2009-01-27	Brantford Chemicals Inc.	A process for the preparation of polypeptides from n-carboxyanhydrides of amino acids
US6936539B2 (en)	2003-09-24	2005-08-30	Micron Technology, Inc.	Antireflective coating for use during the manufacture of a semiconductor device
DK1799703T3 (da)	2004-09-09	2010-04-19	Teva Pharma	Fremgangsmåde til fremstilling af blandinger af polypeptider ved hjælp af oprenset hydrogenbromid
DE602005016292D1 (de) *	2004-10-29	2009-10-08	Sandoz Ag	Verfahren zur herstellung von glatiramer
US8420605B2 (en) *	2005-09-07	2013-04-16	The University Of Strathclyde	Hydrogel compositions

2005
- 2005-10-27 DE DE602005016292T patent/DE602005016292D1/de not_active Expired - Lifetime
- 2005-10-27 SI SI200530809T patent/SI1807467T1/sl unknown
- 2005-10-27 JP JP2007539184A patent/JP5297653B2/ja not_active Expired - Fee Related
- 2005-10-27 AT AT05824006T patent/ATE440888T1/de active
- 2005-10-27 AR ARP050104513A patent/AR052321A1/es not_active Application Discontinuation
- 2005-10-27 CN CN2005800357997A patent/CN101044188B/zh not_active Expired - Fee Related
- 2005-10-27 CA CA2583589A patent/CA2583589C/en not_active Expired - Fee Related
- 2005-10-27 ES ES05824006T patent/ES2331015T3/es not_active Expired - Lifetime
- 2005-10-27 EP EP05824006A patent/EP1807467B1/de not_active Expired - Lifetime
- 2005-10-27 WO PCT/US2005/039003 patent/WO2006050122A1/en not_active Ceased
- 2005-10-27 AU AU2005302500A patent/AU2005302500B2/en not_active Ceased
- 2005-10-28 US US11/262,122 patent/US20060154862A1/en not_active Abandoned
- 2005-10-28 TW TW094137997A patent/TWI307349B/zh not_active IP Right Cessation
2007
- 2007-04-16 IL IL182581A patent/IL182581A/en not_active IP Right Cessation
- 2007-09-27 US US11/904,422 patent/US8536305B2/en not_active Expired - Fee Related
2010
- 2010-03-18 US US12/726,571 patent/US8729229B2/en not_active Expired - Fee Related
- 2010-03-19 US US12/727,758 patent/US20100174048A1/en not_active Abandoned
- 2010-03-19 US US12/727,653 patent/US20100234566A1/en not_active Abandoned
2014
- 2014-07-10 IL IL233618A patent/IL233618A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL182581A (en)	2015-09-24
DE602005016292D1 (de)	2009-10-08
JP5297653B2 (ja)	2013-09-25
US20080021200A1 (en)	2008-01-24
US8729229B2 (en)	2014-05-20
IL233618A0 (en)	2014-08-31
CA2583589C (en)	2012-04-24
AU2005302500A1 (en)	2006-05-11
US20060154862A1 (en)	2006-07-13
EP1807467A1 (de)	2007-07-18
JP2008518930A (ja)	2008-06-05
CA2583589A1 (en)	2006-05-11
SI1807467T1 (sl)	2009-12-31
US20100174048A1 (en)	2010-07-08
IL182581A0 (en)	2007-07-24
ES2331015T3 (es)	2009-12-18
US20100234272A1 (en)	2010-09-16
TWI307349B (en)	2009-03-11
IL233618A (en)	2016-05-31
TW200634051A (en)	2006-10-01
CN101044188A (zh)	2007-09-26
WO2006050122A1 (en)	2006-05-11
US20100234566A1 (en)	2010-09-16
US8536305B2 (en)	2013-09-17
AR052321A1 (es)	2007-03-14
CN101044188B (zh)	2010-08-04
AU2005302500B2 (en)	2008-11-27
EP1807467B1 (de)	2009-08-26

Legal Events

Date

Code

Title

Description

2010-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1807467

Country of ref document: EP

Publication	Publication Date	Title
ATE408609T1 (de)	2008-10-15	Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
DE602005019848D1 (de)	2010-04-22	Verfahren zur herstellung von tad- getrocknetem ti
ATE408604T1 (de)	2008-10-15	Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE399761T1 (de)	2008-07-15	Verfahren zur herstellung von dinitrilen
ATE516816T1 (de)	2011-08-15	Verfahren zur herstellung von impfstoffen
ATE479409T1 (de)	2010-09-15	Verfahren zur herstellung von saugkernen
ATE455105T1 (de)	2010-01-15	Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
DE602005016292D1 (de)	2009-10-08	Verfahren zur herstellung von glatiramer
ATE476411T1 (de)	2010-08-15	Verfahren zur herstellung von 3-pentennitril
DE602006015090D1 (de)	2010-08-05	Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE480531T1 (de)	2010-09-15	Verfahren zur herstellung von benzopyran-2- olderivaten
ATE489015T1 (de)	2010-12-15	Verfahren zur herstellung von verschlüssen
ATE457969T1 (de)	2010-03-15	Verfahren zur herstellung von aloe-emodin
ATE308524T1 (de)	2005-11-15	Verfahren zur herstellung von aripiprazole
ATE399157T1 (de)	2008-07-15	Verfahren zur herstellung von telmisartan
DE602004022134D1 (de)	2009-09-03	Verfahren zur herstellung von dinitrilen
DE502004004318D1 (de)	2007-08-23	Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE553103T1 (de)	2012-04-15	Verfahren zur herstellung von (s)-pantoprazol
DE502005001997D1 (de)	2007-12-27	Verfahren zur herstellung von silanisierten kohlenstoff-nanoröhren
ATE453619T1 (de)	2010-01-15	Verfahren zur herstellung von hydroperoxiden
DE50303611D1 (de)	2006-07-06	Verfahren zur herstellung von polyisobuten
ATE444303T1 (de)	2009-10-15	Verfahren zur herstellung von ferrisuccinylcasein
ATE406372T1 (de)	2008-09-15	Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
ATE466843T1 (de)	2010-05-15	Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
ATE549314T1 (de)	2012-03-15	Verfahren zur herstellung von 4-aminochinazolinen